Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amino acid sequences capable of facilitating penetration across a biological barrier

a technology of amino acid sequences and biological barriers, applied in the direction of macromolecule non-active ingredients, peptide/protein ingredients, depsipeptides, etc., can solve the problems of limited hydrophobic process, limited entry of molecules through the paracellular pathway, and limiting the absorption of larger hydrophilic molecules, so as to achieve the effect of translocating effectors across the biological membran

Inactive Publication Date: 2006-11-09
CHIASMA INC
View PDF8 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0034] The invention also involves methods of translocating an effector across a biological barrier by using the penetration compositions of the invention. For example, an effector can be coupled to penetration compositions according to the invention, which can then be introduced to a biological barrier, thereby effectively translocating the effector across the biological membrane.

Problems solved by technology

Active or facilitative transport occurs via cellular carriers, and is limited to transport of low molecular weight degradation products of complex molecules such as proteins and sugars, e.g., amino acids, pentoses, and hexoses.
This process is limited to relatively small hydrophobic compounds.
Consequently, with the exception of those molecules that are transported by active or facilitative mechanisms, absorption of larger, more hydrophilic molecules is, for the most part, limited to the paracellular pathway.
However, the entry of molecules through the paracellular pathway is primarily restricted by the presence of the tight junctions.
Therefore, large hydrophilic molecules of therapeutic value present a difficult problem in the field of drug delivery.
While they are readily soluble in water, and thus easily dissolve in physiological media, such molecules are barred from absorption by the mucosal layer due to their cell-membrane impermeability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amino acid sequences capable of facilitating penetration across a biological barrier
  • Amino acid sequences capable of facilitating penetration across a biological barrier
  • Amino acid sequences capable of facilitating penetration across a biological barrier

Examples

Experimental program
Comparison scheme
Effect test

example 1

Utilization of the Penetration Composition to Enable the Translocation of Aminoglycoside Antibiotics Across an Epithelial Barrier

[0126] SEQ ID NO: 34 (or any other sequence from SEQ ID NO:22, 30-37) is hydrophobized via acylation of the free amino groups of the two lysine residues at the C-terminus of the penetrating peptide with a fatty acid, i.e., myristoyl. Similarly, any other sequence from SEQ ID NO: 1-15, 24-29 may be also supplemented by extra lysine residues, interspaced by glycine, alanine or serine residues, added at the penetrating peptide C-terminus, and the free amino groups of such lysine residues are acylated with a fatty acid. The hydrophobized peptide is then incorporated into the penetrating composition, which further contains a lyophilizate of (1) an aminoglycoside antibiotic, i.e., gentamycin, (2) an amphipathic counter anion, such as sodium dodecyl sulfate (SDS) or dioctyl sulfosuccinate (DSS) and (3) phytic acid. Additional constituents are specified in Table ...

example 2

Utilization of the Penetration Composition to Enable the Translocation of Cationic Antifungal Agents Such as Caspofungin Across an Epithelial Barrier

[0129] SEQ ID NO: 34 (or any other sequence from SEQ ID NO:22, 30-37) is hydrophobized via acylation of the free amino groups of the two lysine residues at the C-terminus of the penetrating peptide with a fatty acid, i.e., myristoyl. Similarly, any other sequence from SEQ ID NO: 1-15, 24-29 may be also supplemented by extra lysine residues, interspaced by glycine, alanine or serine residues, added at the penetrating peptide C-terminus, and the free amino groups of such lysine residues are acylated with a fatty acid. The hydrophobized peptide is then incorporated into the penetrating composition, which further contains a lyophilizate of (1) an antifungal agent, i.e., caspofungin, (2) an amphipathic counter anion, such as sodium dodecyl sulfate (SDS) or dioctyl sulfosuccinate (DSS) and (3) phytic acid. Additional constituents are specifi...

example 3

Utilization of the Penetration Composition for Mucosal Vaccination

[0132] SEQ ID NO: 34 (or any other sequence from SEQ ID NO:22, 30-37) is hydrophobized via acylation of the free amino groups of the two lysine residues at the C-terminus of the penetrating peptide with a fatty acid, i.e., myristoyl. Similarly, any other sequence from SEQ ID NO: 1-15, 24-29 may be also be supplemented by extra lysine residues, interspaced by glycine, alanine or serine residues, added at the penetrating peptide C-terminus, and the free amino groups of such lysine residues are acylated with a fatty acid. The hydrophobized peptide is then incorporated into the penetrating composition, which further contains a lyophilizate of (1) a desired antigenic sequence, e.g., the HBs antigen of Hepatitis B, (2) an amphipathic counter anion, such as sodium dodecyl sulfate (SDS) or dioctyl sulfosuccinate (DSS) and (3) phytic acid. Additional constituents are specified in Table 3. Such a pharmaceutical composition can...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
compositionaaaaaaaaaa
impermeableaaaaaaaaaa
Login to View More

Abstract

This invention relates to novel pharmaceutical penetration compositions capable of facilitating penetration of at least one effector across biological barriers. The invention also relates to methods of treating or preventing diseases by administering penetration compositions to affected subjects.

Description

RELATED APPLICATIONS [0001] This application is a divisional application of U.S. Ser. No. 10 / 665,184, filed Sep. 17, 2003, which is a continuation-in-part of PCT / IB03 / 00968, filed on Feb. 7, 2003, which claims priority to U.S. Ser. No. 60 / 355,396, filed Feb. 7, 2002, each of which is incorporated herein by reference in its entirety.TECHNICAL FIELD OF THE INVENTION [0002] This invention relates to novel penetration compositions capable of facilitating penetration of an effector across biological barriers. BACKGROUND OF THE INVENTION [0003] Techniques enabling efficient transfer of a substance of interest across a biological barrier are of considerable interest in the field of biotechnology. For example, such techniques may be used for the transport of a variety of different substances across a biological barrier regulated by tight junctions (i.e., the mucosal epithelia, which includes the intestinal and respiratory epithelia and the vascular endothelia, which includes the blood-brain...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/16A61K9/48A61K9/20A61K47/16A61K31/337A61K31/519A61K31/727A61K38/00A61K38/04A61K38/22A61K38/27A61K38/28A61K38/48A61K38/55A61K39/00A61K39/07A61K47/28A61K47/34A61K47/42A61K47/48A61P3/00A61P3/02A61P3/04A61P3/10A61P5/00A61P7/02A61P7/04A61P9/00A61P9/10A61P9/14A61P15/08A61P19/10A61P25/14A61P25/16A61P25/28A61P35/00C07K7/08C07K14/195C07K14/21C07K14/245C07K14/28C07K14/285C07K14/295C07K14/32C07K14/705C07K19/00
CPCA61K38/00A61K39/00C07K14/195C07K14/21C07K14/245C07K14/70571C07K14/285C07K14/295C07K14/32C07K14/705C07K14/28A61P15/08A61P19/10A61P25/14A61P25/16A61P25/28A61P3/00A61P3/02A61P35/00A61P3/04A61P5/00A61P7/02A61P7/04A61P9/00A61P9/10A61P9/14A61P3/10
Inventor BEN-SASSON, SHMUELCOHEN, EINAT
Owner CHIASMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com